MediciNova (MNOV) Short Interest Ratio & Short Volume $1.46 +0.01 (+0.34%) As of 04/17/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MediciNova Short Interest DataMediciNova (MNOV) has a short interest of 231,500 shares, representing 0.50% of the float (the number of shares available for trading by the public). This marks a -4.06% decrease in short interest from the previous month. The short interest ratio (days to cover) is 11.5, indicating that it would take 11.5 days of the average trading volume of 38,620 shares to cover all short positions.Current Short Interest231,500 sharesPrevious Short Interest241,300 sharesChange Vs. Previous Month-4.06%Dollar Volume Sold Short$337,990.00Short Interest Ratio11.5 Days to CoverLast Record DateMarch 31, 2025Outstanding Shares49,046,000 sharesFloat Size46,480,000 sharesShort Percent of Float0.50%Today's Trading Volume6,458 sharesAverage Trading Volume38,620 sharesToday's Volume Vs. Average17% Short Selling MediciNova? Sign up to receive the latest short interest report for MediciNova and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMNOV Short Interest Over TimeMNOV Days to Cover Over TimeMNOV Percentage of Float Shorted Over Time MediciNova Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2025231,500 shares $337,990.00 -4.1%0.5%11.5 $1.46 3/15/2025241,300 shares $374,015.00 -11.7%0.5%10.5 $1.55 2/28/2025273,400 shares $448,376.00 -9.1%0.6%9.7 $1.64 2/15/2025300,700 shares $592,379.00 -4.7%0.7%8.2 $1.97 1/31/2025315,600 shares $624,888.00 -13.6%0.7%4.3 $1.98 1/15/2025365,400 shares $683,298.00 +1.2%0.8%4.9 $1.87 12/31/2024361,100 shares $758,310.00 +4.5%0.8%5 $2.10 12/15/2024345,700 shares $725,970.00 +3.4%0.7%4.9 $2.10 11/30/2024334,300 shares $692,001.00 -5.0%0.7%4.8 $2.07 11/15/2024351,800 shares $643,794.00 +93.1%0.8%4.3 $1.83 Get the Latest News and Ratings for MNOV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MediciNova and its competitors with MarketBeat's FREE daily newsletter. 10/31/2024182,200 shares $306,096.00 -8.1%0.4%4.7 $1.68 10/15/2024198,200 shares $358,742.00 +0.7%0.4%5.2 $1.81 9/30/2024196,800 shares $413,280.00 -12.4%0.4%5.2 $2.10 9/15/2024224,600 shares $408,772.00 +19.3%0.5%5.7 $1.82 8/31/2024188,200 shares $282,300.00 +104.3%0.4%4.6 $1.50 8/15/202492,100 shares $106,836.00 -2.0%0.2%4.4 $1.16 7/31/202494,000 shares $125,960.00 -13.8%0.2%4.2 $1.34 7/15/2024109,000 shares $154,780.00 +6.0%0.2%5 $1.42 6/30/2024102,800 shares $148,032.00 -7.1%0.2%4.2 $1.44 6/15/2024110,700 shares $147,231.00 -18.4%0.2%3.2 $1.33 5/31/2024135,600 shares $184,416.00 -14.5%0.3%4.3 $1.36 5/15/2024158,600 shares $233,142.00 -25.5%0.3%4.4 $1.47 4/30/2024212,900 shares $274,641.00 -13.8%0.5%4.4 $1.29 4/15/2024247,000 shares $380,380.00 -26.0%0.5%5 $1.54 3/31/2024333,600 shares $483,720.00 +2.3%0.7%6.2 $1.45 3/15/2024326,000 shares $423,800.00 -3.5%0.7%5.6 $1.30 2/29/2024337,800 shares $456,030.00 +34.5%0.7%5.7 $1.35 2/15/2024251,200 shares $339,120.00 +3.3%0.5%4.1 $1.35 1/31/2024243,100 shares $342,771.00 -24.8%0.5%2.1 $1.41 1/15/2024323,400 shares $485,100.00 -8.3%0.7%2.8 $1.50 12/31/2023352,600 shares $528,900.00 -6.5%0.8%3.2 $1.50 12/15/2023377,100 shares $588,276.00 +0.5%0.8%3.6 $1.56 11/30/2023375,100 shares $678,931.00 +57.7%0.8%3.8 $1.81 11/15/2023237,800 shares $418,528.00 -2.3%0.5%2.5 $1.76 10/31/2023243,400 shares $464,894.00 -20.7%0.5%11.6 $1.91 10/15/2023307,000 shares $614,000.00 -16.1%0.7%14.3 $2.00 9/30/2023365,700 shares $764,313.00 -1.8%0.8%17.3 $2.09 9/15/2023372,400 shares $759,696.00 +0.8%0.8%19.8 $2.04 8/31/2023369,500 shares $901,580.00 +0.4%0.8%18.1 $2.44 8/15/2023368,100 shares $850,311.00 -0.3%0.8%18.9 $2.31Trump to unlock 15-figure fortune for America (May 3rd) ? (Ad)We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America. Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking. And he believes Trump could soon release this frozen asset to the public. But something even more spectacular is bound to happen. And those who know what to expect could make 7/31/2023369,300 shares $878,934.00 -2.1%0.8%20.6 $2.38 7/15/2023377,300 shares $965,888.00 +0.7%0.8%20.6 $2.56 6/30/2023374,800 shares $862,040.00 +5.6%0.8%18.3 $2.30 6/15/2023354,800 shares $819,588.00 +4.7%0.8%18.1 $2.31 5/31/2023339,000 shares $728,850.00 -4.6%0.7%17.6 $2.15 5/15/2023355,400 shares $783,657.00 +1.6%0.8%17.9 $2.21 4/30/2023349,700 shares $737,867.00 -0.6%0.8%16.7 $2.11 4/15/2023351,800 shares $809,140.00 +3.9%0.8%16.4 $2.30 3/31/2023338,700 shares $731,592.00 -1.1%0.7%13.3 $2.16 3/15/2023342,600 shares $719,460.00 -5.4%0.7%7.5 $2.10 2/28/2023362,100 shares $796,620.00 -0.2%0.8%5.4 $2.20 2/15/2023362,800 shares $838,068.00 -3.1%0.8%4.9 $2.31 1/31/2023374,500 shares $895,055.00 -0.9%0.8%4.7 $2.39 1/15/2023377,800 shares $936,944.00 -3.8%0.8%4.6 $2.48 12/30/2022392,700 shares $805,035.00 -25.7%0.9%4.8 $2.05 12/15/2022528,700 shares $1.24 million +20.9%1.1%7.4 $2.35 11/30/2022437,200 shares $1.15 million -34.7%0.9%10.1 $2.64 11/15/2022669,300 shares $1.44 million -17.6%1.4%18.5 $2.15 10/31/2022812,400 shares $1.66 million +0.1%1.8%26.9 $2.04 10/15/2022811,600 shares $1.62 million -15.6%1.8%30.2 $1.99 9/30/2022961,000 shares $2.09 million -11.8%2.1%36 $2.17 9/15/20221,090,000 shares $2.40 million -3.5%2.4%45.4 $2.20 8/31/20221,130,000 shares $2.41 million -1.7%2.4%48.3 $2.13 8/15/20221,150,000 shares $2.85 million No Change2.5%45.6 $2.48 7/31/20221,150,000 shares $2.66 million -4.2%2.4%42.6 $2.31 7/15/20221,200,000 shares $2.86 million -0.8%2.5%41.4 $2.38 6/30/20221,210,000 shares $3.06 million -2.4%2.5%34 $2.53 6/15/20221,240,000 shares $3.16 million -0.8%3.5%28.8 $2.55 5/31/20221,250,000 shares $3.04 million +0.8%2.7%28.3 $2.43 5/15/20221,240,000 shares $2.99 million -7.5%2.7%26.1 $2.41 4/30/20221,340,000 shares $3.58 million -3.6%2.9%26.3 $2.67 4/15/20221,390,000 shares $4.25 million -4.1%3.0%14.6 $3.06 3/31/20221,450,000 shares $3.87 million No Change3.1%14.3 $2.67 3/15/20221,450,000 shares $3.34 million -13.7%3.1%12.3 $2.30 2/28/20221,680,000 shares $4.02 million -2.9%3.6%10.7 $2.39 2/15/20221,730,000 shares $4.26 million +10.9%3.7%3.2 $2.46 1/31/20221,560,000 shares $3.78 million -12.4%3.4%2.9 $2.42 1/15/20221,780,000 shares $4.49 million -1.1%3.8%3.5 $2.52 12/31/20211,800,000 shares $4.82 million -4.8%3.9%3.6 $2.68 12/15/20211,890,000 shares $5.42 million -17.5%4.1%3.8 $2.87 11/30/20212,290,000 shares $7.51 million +30.1%4.9%4.9 $3.28 11/15/20211,760,000 shares $6.21 million +2.9%3.8%4.1 $3.53 10/29/20211,710,000 shares $5.75 million +0.6%3.7%14.3 $3.36 10/15/20211,700,000 shares $6.49 million -1.7%3.7%13.9 $3.82 9/30/20211,730,000 shares $6.56 million -9.0%3.7%10.8 $3.79 9/15/20211,900,000 shares $7.58 million -0.5%4.1%5.7 $3.99 8/31/20211,910,000 shares $7.47 million -5.9%4.1%2.3 $3.91 8/13/20212,030,000 shares $7.13 million -1.9%4.4%2.4 $3.51 7/30/20212,070,000 shares $7.51 million -2.8%4.5%2.5 $3.63 7/15/20212,130,000 shares $7.88 million -9.8%4.6%2.4 $3.70Trump to unlock 15-figure fortune for America (May 3rd) ? (Ad)We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America. Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking. And he believes Trump could soon release this frozen asset to the public. But something even more spectacular is bound to happen. And those who know what to expect could make 6/30/20212,360,000 shares $10.03 million -40.1%5.1%2.6 $4.25 6/15/20213,940,000 shares $16.15 million +1.0%8.5%5 $4.10 5/28/20213,900,000 shares $16.46 million -0.5%8.4%8.3 $4.22 5/14/20213,920,000 shares $15.88 million +6.2%N/A4.2 $4.05 4/30/20213,690,000 shares $17.42 million +17.9%N/A4 $4.72 4/15/20213,130,000 shares $14.49 million +1.6%N/A3.5 $4.63 3/31/20213,080,000 shares $15.25 million -2.2%N/A3.5 $4.95 3/15/20213,150,000 shares $18.99 million +36.4%N/A3.6 $6.03 2/26/20212,310,000 shares $12.57 million +3.1%N/A10.4 $5.44 2/12/20212,240,000 shares $14.29 million -17.7%N/A11.1 $6.38 1/29/20212,720,000 shares $15.83 million -2.2%6.7%12.9 $5.82 1/15/20212,780,000 shares $15.90 million -4.1%6.9%13.3 $5.72 12/31/20202,900,000 shares $14.99 million +12.8%7.2%15.3 $5.17 12/15/20202,570,000 shares $15.42 million -7.9%6.4%11.5 $6.00 11/30/20202,790,000 shares $16.66 million -15.2%6.9%6 $5.97 11/15/20203,290,000 shares $19.87 million +2.2%8.2%7 $6.04 10/30/20203,220,000 shares $18.39 million +2.9%8.0%6.7 $5.71 10/15/20203,130,000 shares $16.46 million -7.7%7.9%1.6 $5.26 9/30/20203,390,000 shares $17.76 million +42.4%8.5%1.7 $5.24 9/15/20202,380,000 shares $13.85 million +3.9%6.1%1.2 $5.82 8/31/20202,290,000 shares $12.00 million -2.6%5.9%1.4 $5.24 8/14/20202,350,000 shares $14.24 million -19.2%6.3%1.5 $6.06 7/31/20202,910,000 shares $18.10 million +21.8%7.8%1.8 $6.22 7/15/20202,390,000 shares $12.74 million +3.5%6.5%18.5 $5.33 6/30/20202,310,000 shares $12.57 million +6.9%6.2%13.1 $5.44 6/15/20202,160,000 shares $13.74 million -4.9%5.8%13.3 $6.36 5/29/20202,270,000 shares $12.12 million +1.8%6.1%12.6 $5.34 5/15/20202,230,000 shares $12.73 million -1.3%6.0%12 $5.71 4/30/20202,260,000 shares $11.64 million -6.2%6.1%12.5 $5.15 MNOV Short Interest - Frequently Asked Questions What is MediciNova's current short interest? Short interest is the volume of MediciNova shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 231,500 shares of MNOV short. 0.50% of MediciNova's shares are currently sold short. Learn More on MediciNova's current short interest. What is a good short interest ratio for MediciNova? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MNOV shares currently have a short interest ratio of 12.0. Learn More on MediciNova's short interest ratio. Which institutional investors are shorting MediciNova? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of MediciNova: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for MediciNova? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.50% of MediciNova's floating shares are currently sold short. Is MediciNova's short interest increasing or decreasing? MediciNova saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 231,500 shares, a decrease of 4.1% from the previous total of 241,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is MediciNova's float size? MediciNova currently has issued a total of 49,046,000 shares. Some of MediciNova's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. MediciNova currently has a public float of 46,480,000 shares. How does MediciNova's short interest compare to its competitors? 0.50% of MediciNova's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to MediciNova: Acelyrin, Inc. (4.99%), Candel Therapeutics, Inc. (12.93%), Solid Biosciences Inc. (12.85%), Aurora Cannabis Inc. (9.02%), Olema Pharmaceuticals, Inc. (14.07%), Compass Therapeutics, Inc. (8.20%), Immutep Limited (3.21%), Bright Minds Biosciences Inc. (2.03%), Foghorn Therapeutics Inc. (3.58%), iTeos Therapeutics, Inc. (5.54%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks. What does it mean to sell short MediciNova stock? Short selling MNOV is an investing strategy that aims to generate trading profit from MediciNova as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against MediciNova? A short squeeze for MediciNova occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MNOV, which in turn drives the price of the stock up even further. How often is MediciNova's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MNOV, twice per month. The most recent reporting period available is March, 31 2025. More Short Interest Resources from MarketBeat Related Companies Acelyrin Short Interest Data Candel Therapeutics Short Interest Data Solid Biosciences Short Interest Data Aurora Cannabis Short Interest Data Olema Pharmaceuticals Short Interest Data Compass Therapeutics Short Interest Data Immutep Short Interest Data Bright Minds Biosciences Short Interest Data Foghorn Therapeutics Short Interest Data iTeos Therapeutics Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MNOV) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredThey Won’t Tell You This About GoldInflation, digital currency, and government policy are quietly eating away at your savings — and most people w...American Alternative | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MediciNova, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MediciNova With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MNOV Stock Free MNOV Stock Alerts